|
|
||||||||
Clinical Trial |
Sheffield Kidney Institute, Northern General Hospital, Sheffield University Hospital Trust, Sheffield, South Yorkshire, United Kingdom. Sbjenksi@hotmail.com
OBJECTIVE: Concerns regarding the impact of ultrafiltration failure on peritoneal dialysis and the effect of hypertonic glucose on the peritoneal membrane have lead to a search for alternative dialysates. Computer simulations based on the three-pore theory suggest that a combination of 1.36% glucose and 7.5% icodextrin (glucose polymer) offers an improved ultrafiltration profile. The aim of the present study was to investigate the ultrafiltration profile of this combination fluid. DESIGN: Prospective open study comparing 1.36% glucose, 3.86% glucose, 7.5% icodextrin, and the combination fluid (1.36% glucose/7.5% icodextrin). SETTING: Sheffield Kidney Institute, Northern General Hospital, Sheffield, UK. PATIENTS: 11 patients currently using peritoneal dialysis not previously exposed to icodextrin. MAIN OUTCOME MEASURE: Intraperitoneal volume was measured using a radioisotope dilution method. RESULTS: The combination fluid showed a biphasic ultrafiltration profile, with a steep initial increase in intraperitoneal volume, then a maintained plateau phase for the duration of the study dwell (7 hours). The final volume was greater than that with the 1.36% glucose dwell and the 7.5% icodextrin dwell. The fluid was well tolerated by the patients. CONCLUSIONS: These findings are in keeping with computer simulations using the three-pore model. The combination fluid offers an improved ultrafiltration profile, with a final volume similar to 3.86% glucose, while avoiding exposing the peritoneal membrane to high glucose concentrations. It may have a role as a long dwell to optimize ultrafiltration and possibly prolong peritoneal dialysis technique survival.
This article has been cited by other articles:
![]() |
C. J. Holmes and W. Smit Future technologies and techniques in peritoneal dialysis--opportunities and challenges ahead NDT Plus, October 1, 2008; 1(suppl_4): iv51 - iv55. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |